NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 19.20
+0.05 (0.26%)
Apr 20, 2026, 12:52 PM CST
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 897.75 million as of April 20, 2026. Its market cap has decreased by -18.54% in one year.
Market Cap
897.75M
Enterprise Value
358.34M
Revenue
180.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.20
Market Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 897.75M, an increase of 213.98%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 900.10M | -7.71% |
| Dec 31, 2025 | 975.30M | -20.71% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.24B |
| Meribank Biotech | 1.16B |
| GeneReach Biotechnology | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.01B |
| TCI GENE | 967.06M |
| BioLASCO Taiwan | 778.60M |